Subarachnoid hemorrhage (SAH) caused by a ruptured cerebral aneurysm is probably the most devastating event that can afect the brain. It is a predominantly medical condition, which, after the initial intervention that stops the bleeding (clipping or coiling), can go on to an important sequela of complications. Te tools available to the intensivist physician are relatively few. Undoubtedly, the most fearsome complication is delayed cerebral ischemia (DCI), defned as the occurrence of focal neurological defcits or loss of at least 2 points on the Glasgow Coma Scale not attributable to other causes.

Aspide, R., Berselli, B., Piazza, O., Recchia, A., Bilotta, F. (2024). Statins in Subarachnoid Hemorrhage to Prevent Delayed Cerebral Ischemia: Old Drugs for New Strategies?. NEUROCRITICAL CARE, 1-2 [10.1007/s12028-024-01989-1].

Statins in Subarachnoid Hemorrhage to Prevent Delayed Cerebral Ischemia: Old Drugs for New Strategies?

Bilotta, Federico
2024-01-01

Abstract

Subarachnoid hemorrhage (SAH) caused by a ruptured cerebral aneurysm is probably the most devastating event that can afect the brain. It is a predominantly medical condition, which, after the initial intervention that stops the bleeding (clipping or coiling), can go on to an important sequela of complications. Te tools available to the intensivist physician are relatively few. Undoubtedly, the most fearsome complication is delayed cerebral ischemia (DCI), defned as the occurrence of focal neurological defcits or loss of at least 2 points on the Glasgow Coma Scale not attributable to other causes.
2024
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-23/A - Anestesiologia
English
Subarachnoid Hemorrhage
Cerebral Ischemia
Aspide, R., Berselli, B., Piazza, O., Recchia, A., Bilotta, F. (2024). Statins in Subarachnoid Hemorrhage to Prevent Delayed Cerebral Ischemia: Old Drugs for New Strategies?. NEUROCRITICAL CARE, 1-2 [10.1007/s12028-024-01989-1].
Aspide, R; Berselli, B; Piazza, O; Recchia, A; Bilotta, F
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
2024 Aspide_et_al-2024-Neurocritical_Care.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 501.32 kB
Formato Adobe PDF
501.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/462589
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 2
social impact